Atrys Health SL
Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of r… Read more
Atrys Health SL (ATRY) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.026x
Based on the latest financial reports, Atrys Health SL (ATRY) has a cash flow conversion efficiency ratio of 0.026x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€6.22 Million) by net assets (€241.53 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Atrys Health SL - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Atrys Health SL's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Atrys Health SL Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Atrys Health SL ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen Tongye Technology Co.Ltd.
SHE:300960
|
-0.016x |
|
SIDETRADE EO 1
F:7QG
|
N/A |
|
Braemar Hotel & Resorts Inc
NYSE:BHR
|
-0.025x |
|
Codere Online US Corp
NASDAQ:CDRO
|
0.166x |
|
Cashbuild Limited
PINK:CBLDF
|
N/A |
|
MC Group Public Company Limited
BK:MC
|
-0.001x |
|
Vestum AB (publ)
ST:VESTUM
|
0.014x |
|
LTC Co.Ltd
KQ:170920
|
-0.014x |
Annual Cash Flow Conversion Efficiency for Atrys Health SL (2015–2024)
The table below shows the annual cash flow conversion efficiency of Atrys Health SL from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €253.24 Million | €3.00 Million | 0.012x | +413.87% |
| 2023-12-31 | €289.88 Million | €-1.09 Million | -0.004x | +91.75% |
| 2022-12-31 | €337.57 Million | €-15.43 Million | -0.046x | -366.86% |
| 2021-12-31 | €273.98 Million | €4.69 Million | 0.017x | +192.45% |
| 2020-12-31 | €75.33 Million | €-1.40 Million | -0.019x | -168.34% |
| 2019-12-31 | €39.95 Million | €1.08 Million | 0.027x | +178.48% |
| 2018-12-31 | €26.44 Million | €-913.68K | -0.035x | -161.14% |
| 2017-12-31 | €23.30 Million | €1.32 Million | 0.057x | +201.57% |
| 2016-12-31 | €14.26 Million | €-793.63K | -0.056x | -258.82% |
| 2015-12-31 | €11.70 Million | €409.89K | 0.035x | -- |